Verrica Pharmaceuticals Inc.
NASDAQ:VRCABiotechnology
Healthcare
$3.14 -0.26%
-$0.02 today
- Market cap
- $53.94M
- Beta
- 1.49
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$1.67
52W Low $3.28High $9.82
Volume 0.10M
Average 0.08M
Balance Sheet
Inspect the capital base behind the business.
Assets
$47.13M
FY 2025 · Annual
-12.9% YoYLiabilities
$22.39M
FY 2025 · Annual
-65.0% YoYEquity
$24.74M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 15.75M | 34.27M | 69.55M | 46.33M | 30.15M |
| Short-term Investments | 54.6M | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 487K | 4.42M | 77K | 5.4M |
| Inventory | 0 | 0 | 1.02M | 2.46M | 2.24M |
| Other Current Assets | 0 | 4.36M | 2.55M | 2.31M | 4.76M |
| Total Current Assets | 74.33M | 39.12M | 77.53M | 51.18M | 42.54M |
| Property, Plant & Equipment (Net) | 5.5M | 5.33M | 3.62M | 2.58M | 1.86M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 295K | 276K | 452K | 376K | 2.73M |
| Total Non-current Assets | 5.8M | 5.61M | 4.07M | 2.96M | 4.59M |
| Total Assets | 80.13M | 44.72M | 81.6M | 54.13M | 47.13M |
| Account Payables | 845K | 507K | 2.46M | 1.9M | 2.07M |
| Short-term Debt | 41.69M | 0 | 0 | 12.94M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 782K |
| Other Current Liabilities | 1.67M | 1.4M | 9.04M | 11.59M | 10.44M |
| Total Current Liabilities | 46.06M | 3.46M | 17.02M | 29.01M | 16.44M |
| Long-term Debt | 0 | 0 | 42.87M | 30.98M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 2.65M | 5.07M |
| Total Non-current Liabilities | 1.47M | 1.23M | 44.81M | 34.98M | 5.95M |
| Total Liabilities | 47.52M | 4.69M | 61.83M | 63.99M | 22.39M |
| Common Stock | 3K | 4K | 4K | 9K | 2K |
| Retained Earnings | (138.97M) | (163.45M) | (230.45M) | (307.03M) | (324.91M) |
| Accumulated OCI | (29K) | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 32.61M | 40.03M | 19.76M | (9.86M) | 24.74M |
| Total Debt | 43.41M | 1.53M | 45.51M | 45.94M | 1.63M |
| Net Debt | 27.66M | (32.75M) | (24.04M) | (390K) | (28.52M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $20.6M |
| Receivables | $7.8M |
| Inventory | $2.0M |
| Other Current | $2.4M |
| Total Current Assets | $32.8M |
| PP&E (Net) | $1.7M |
| Long-term Investments | $264.0K |
| Other Non-current | $4.1M |
| Total Non-current Assets | $6.0M |
| Total Assets | $38.8M |
Analysis
Selected assets total $38.8M for Latest. The largest visible component is Cash & Equivalents at $20.6M, about 53.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 18, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 18, 2026 |
How much cash does VRCA have?
Verrica Pharmaceuticals Inc. (VRCA) reported $30.15M in cash and equivalents in fiscal 2025.
How much debt does VRCA carry?
Verrica Pharmaceuticals Inc. (VRCA) reported $1.63M of total debt, with net debt of -$28.52M.
Continue the stock analysis
Jump to another research area for this company.